ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1032

Impact of a Coordinated Care Model for Addressing Rheumatoid Arthritis and Associated Comorbidities

Alexis Barbut1, Marsha Jackson2, Krista Kowiak2, Julie McIntyre2 and Allen Anandarajah1, 1University of Rochester Medical Center, Rochester, NY, 2University of Rochester Medical Center, Rochester

Meeting: ACR Convergence 2024

Keywords: Access to care, Outcome measures, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Healthcare Disparities in Rheumatology Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid Arthritis (RA) is often associated with comorbidities including hypertension, cardiovascular disease, osteoporosis, lung disease, and eye involvement. Studies suggests that the average RA patient has 1.6 comorbid conditions which is higher as compared to the general population.1 Moreover, there is a higher presence of comorbidities among marginalized communities. RA patients with comorbidities suffer higher levels of pain and depression and have lower levels of physical function and overall quality of life. Addressing the needs of RA patients with multimodality thus requires developing new practice models to incorporate the realities of comorbidities, reducing duplicative services and adopting a patient-centered approach.

Methods: We developed an integrated, patient-centric, coordinated care model, RA CHAMP program, that in addition to standard of clinical care, our program utilizes self-management to improve quality of life for RA patents with multimorbidity. The RA CHAMP program focuses on following objectives (a) effective use of community resources (b) coordinate with other specialists for early referrals (c) enable early access to rheumatology care (d) encourage medication adherence (e) encourage physical activity. Self-management programs are organized monthly, via zoom, and led by a physician assistant and nurse. This is followed by 30 minutes of exercises led by a physical therapist. Patients with more than 1 comorbidity were invited to join the RA CHAMP program. We then evaluated the benefits of the program on physical function, depression and pain, as measured using PROMIS, at baseline and a year later. Additionally, a patient survey was used to rate the program on a Likert scale of 1-5 and on the likelihood of them implementing a regular exercise regimen (1-5).

Results: A total of 45 patient have enrolled to date in the RA CHAMP program. This group comprised 27 subjects with RA. This comprised 23 females (85.1%) and 4 males (14.8%) and included 17 Caucasians (62.9%), 7 Black patients (25.9), 1 Hispanic (3.7%), 1 American Indian (3.7%) and 1 Asian (3.7%). A total of 25 (92.6%) were seropositive and 15 (55.6%) had erosive disease. The average age of patients was 69.4 years old, and the average disease duration was 15.2 years. Twenty patients (74%) were on conventional DMARDs and 15 (55.6%) were on biologics (see Table 1). Comorbidities were seen in 26 (96.2%) of patients with hypertension being most common followed by osteoporosis. Our cohort had on average 1.96 comorbidities.

PROMIS scores were available for 25 of the 27 patients at baseline and 1 year after enrolling in the program. The mean scores for depression were 53.7 at baseline and improved 46.7 at one year. Mean scores for pain also improved from 65.2 to 58.8. Mean scores for physical function improved from 35.8 to 41.9 (see Fig 1).

Conclusion: A patient centric program that incorporates care coordination and uses self-management results in improvement in physical function, pain, and depression in most patients with RA and empowers patients to take responsibility for their treatment. Larger and longer studies will help confirm these findings.

Supporting image 1

Table 1: Patient demographics and clinical characteristics

Supporting image 2

Figure 2: Mean PROMIS Scores at baseline and 12 months after enrolling in program


Disclosures: A. Barbut: None; M. Jackson: None; K. Kowiak: None; J. McIntyre: None; A. Anandarajah: None.

To cite this abstract in AMA style:

Barbut A, Jackson M, Kowiak K, McIntyre J, Anandarajah A. Impact of a Coordinated Care Model for Addressing Rheumatoid Arthritis and Associated Comorbidities [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/impact-of-a-coordinated-care-model-for-addressing-rheumatoid-arthritis-and-associated-comorbidities/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-a-coordinated-care-model-for-addressing-rheumatoid-arthritis-and-associated-comorbidities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology